Healthcare Global Enterprises Li (NSE: HCG) and Yatharth Hospital & Trauma Care Services Ltd (NSE: YATHARTH) are both listed in the Hospitals and Healthcare Centers industry. Healthcare Global Enterprises Li has a market capitalisation of ₹8,761 Cr and Yatharth Hospital & Trauma Care Services ₹9,042 Cr, as of 9 Nov 2026. Their P/E ratios are 611.3 and 51.6 respectively. Return on equity is 1.90% for Healthcare Global Enterprises Li and 9.89% for Yatharth Hospital & Trauma Care Services. Over one year, Healthcare Global Enterprises Li's share price is down 22.0% and Yatharth Hospital & Trauma Care Services's is up 30.1%.
| Metric | Healthcare Global Enterprises Li | Yatharth Hospital & Trauma Care Services |
|---|---|---|
| NSE Symbol | HCG | YATHARTH |
| BSE Code | 539787 | 543950 |
| Share Price | ₹587.10 | ₹1,059.00 |
| Market Cap | ₹8,761 Cr | ₹9,042 Cr |
| P/E Ratio | 611.3 | 51.6 |
| Return on Equity | 1.90% | 9.89% |
| Return on Assets | 3.81% | 6.39% |
| Dividend Yield | — | 0.11% |
| Beta (1Y) | 0.35 | 0.47 |
| 1-Year Price Change | -22.0% | +30.1% |
| 3-Month Price Change | -18.0% | +17.8% |
| 52-Week Range | ₹513.30 – ₹775.00 | ₹538.25 – ₹1,184.00 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹732 Cr | ₹431 Cr |
| Quarterly Net Profit | ₹9 Cr | ₹48 Cr |
| Net Margin | 1.3% | 11.2% |
| EPS (Basic, Quarter) | ₹0.32 | ₹5.25 |
| Results Basis | consolidated | consolidated |
| Headquarters | Bengaluru, Karnataka | Noida, Uttar Pradesh |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marro…
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney tr…
Yatharth Hospital & Trauma Care Services has a market capitalisation of ₹9,042 Cr, against ₹8,761 Cr for Healthcare Global Enterprises Li as of 9 Nov 2026, so the two are about the same size by market cap.
Healthcare Global Enterprises Li has a P/E of 611.3 and Yatharth Hospital & Trauma Care Services a P/E of 51.6 as of 9 Nov 2026.
Healthcare Global Enterprises Li has a return on equity of 1.90% and Yatharth Hospital & Trauma Care Services 9.89%.
Healthcare Global Enterprises Li's share price is down 22.0% over one year and Yatharth Hospital & Trauma Care Services's is up 30.1%.
Healthcare Global Enterprises Li reported revenue of ₹732 Cr and net profit of ₹9 Cr for Q2 FY27. Yatharth Hospital & Trauma Care Services reported revenue of ₹431 Cr and net profit of ₹48 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.